Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:14 am Purchase | 2024-12-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Altium Capital Management LLC | 193,877 3.900% | 193,877 (New Position) | Filing History |
| 2025-02-14 11:10 am Purchase | 2024-12-31 | 13G | Better Choice Company Inc. BTTR | Altium Capital Management LLC | 463,459 6.100% | 118,459 (+34.34%) | Filing History |
| 2025-02-05 6:24 pm Purchase | 2025-01-28 | 13G | Sharps Technology, Inc. STSS | Altium Capital Management LLC | 549,294 9.990% | 549,294 (New Position) | Filing History |
| 2024-11-14 09:22 am Unchanged | 2024-09-30 | 13G | Volcon, Inc. VLCN | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 09:21 am Purchase | 2024-09-30 | 13G | Skye Bioscience, Inc. SKYE | Altium Capital Management LLC | 1,315,146 4.300% | 13,628 (+1.05%) | Filing History |
| 2024-11-14 09:19 am Purchase | 2024-09-30 | 13G | Evoke Pharma, Inc. EVOK | Altium Capital Management LLC | 153,186 4.990% | 153,186 (New Position) | Filing History |
| 2024-11-14 09:16 am Unchanged | 2024-09-30 | 13G | Better Choice Company Inc. BTTR | Altium Capital Management LLC | 345,000 7.300% | 0 (Unchanged) | Filing History |
| 2024-09-26 6:28 pm Purchase | 2024-09-23 | 13G | Elevai Labs, Inc. Common Stock ELAB | Altium Capital Management LLC | 28,571 9.990% | 28,571 (New Position) | Filing History |
| 2024-08-16 5:32 pm Purchase | 2024-08-08 | 13G | Expion360 Inc. XPON | Altium Capital Management LLC | 150,000 9.990% | 150,000 (New Position) | Filing History |
| 2024-08-09 4:56 pm Purchase | 2024-08-05 | 13G | LogicMark, Inc. LGMK | Altium Capital Management LLC | 95,411 9.990% | 95,411 (New Position) | Filing History |
| 2024-08-09 4:52 pm Purchase | 2024-07-30 | 13G | Better Choice Company Inc. BTTR | Altium Capital Management LLC | 345,000 5.800% | 345,000 (New Position) | Filing History |
| 2024-05-08 6:02 pm Purchase | 2024-05-01 | 13G | Cemtrex, Inc. CETX | Altium Capital Management LLC | 1,005 9.990% | 1,005 (New Position) | Filing History |
| 2024-02-21 4:28 pm Purchase | 2024-02-13 | 13G | Sunshine Biopharma, Inc. SBFM | Altium Capital Management LLC | 4,500 9.990% | 4,500 (New Position) | Filing History |
| 2024-02-20 4:38 pm Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | Altium Capital Management LLC | 153,186 9.700% | 153,186 (New Position) | Filing History |
| 2024-02-13 5:19 pm Purchase | 2023-12-31 | 13G | Volcon, Inc. VLCN | Altium Capital Management LLC | 2,083 9.900% | 2,083 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Altium Capital Management LLC | 18,132 4.990% | 18,132 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 97,632 4.990% | 83,684 (+600.00%) | Filing History |
| 2024-02-13 5:15 pm Unchanged | 2023-12-31 | 13G | Marpai, Inc. MRAI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:10 pm Purchase | 2023-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 8,027,593 6.200% | 1,529,675 (+23.54%) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 194,100 4.990% | 0 (Unchanged) | Filing History |